BC Week In Review | Jan 30, 2012
Company News

Castle Biosciences, Indiana University Research and Technology deal

Castle received exclusive, worldwide rights from the not-for-profit to IP related to the biotech's DecisionDx-Thymoma test to detect the likelihood of metastasis in thymic cancer. Details were not disclosed. Castle recently completed technical validation of...
Items per page:
1 - 1 of 1